Pre-made Crotedumab benchmark antibody ( Whole mAb, anti-GCGR therapeutic antibody, Anti-GGR/GL-R/MVAH Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-124

Pre-Made Crotedumab biosimilar, Whole mAb, Anti-GCGR Antibody: Anti-GGR/GL-R/MVAH therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Crotedumab (REGN1193) (INN) is a humanized monoclonal antibody designed for the treatment of diabetes.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-124-1mg 1mg 3090
GMP-Bios-ab-124-10mg 10mg Inquiry
GMP-Bios-ab-124-100mg 100mg Inquiry
GMP-Bios-ab-124-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Crotedumab biosimilar, Whole mAb, Anti-GCGR Antibody: Anti-GGR/GL-R/MVAH therapeutic antibody
INN Name Crotedumab
TargetGCGR
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2015
Year Recommended2016
CompaniesRegeneron Pharmaceuticals;Sanofi
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedType 2 diabetes mellitus
Development Techna